We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ruchika Talwar

Ruchika Talwar MD

Chief Resident, Division of Urology, Department of Surgery; Associate Fellow, Leonard Davis Institute for Health Economics, University of Pennsylvania Health System, Philadelphia, Pennsylvania

Dr. Talwar is a chief resident at the University of Pennsylvania in Philadelphia, and an associate fellow at Wharton's Leonard Davis Institute for Health Economics. She is pursuing a career in urologic oncology and health policy, and will be completing an SUO fellowship at Vanderbilt University in Nashville. She has published extensively on opioid usage after urologic surgery and was a co-author of the AUA White Paper, "Rationale and Strategies for Reducing Urologic Post-Operative Opioid Prescribing." Dr. Talwar is an active member of the AUA Public Policy initiatives, and is a delegate representing the AUA within the American Medical Association. Additional academic interests include quality improvement, health equity, and access to care.

Disclosures

Dr. Talwar has no relevant disclosures.